Literature DB >> 19182922

The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda.

Isaac Ssewanyana1, Chris A R Baker, Theodore Ruel, Stephanie Bousheri, Moses Kamya, Grant Dorsey, Philip J Rosenthal, Edwin Charlebois, Diane Havlir, Huyen Cao.   

Abstract

Abstract T cell activation is an important mechanism in HIV-associated immune depletion. We have previously demonstrated an association between the hyperactivation of CD4(+) and CD8(+) T cells and low CD4 status in HIV-infected Ugandan children. In this study, we explore differences in activation between naive and memory T cells in HIV-infected Ugandan children. A significant correlation between CD4- and CD8-mediated immune activation and CD4 status was observed only in the memory T cells. Antiretroviral (ART) untreated and treated HIV-positive and HIV-negative children displayed similar profiles of activation and distribution within the CD4(+) naive T cells. In contrast, significantly higher immune activation of the memory CD4(+) T cell subset was seen in ART-untreated children when compared to ART-treated or HIV-negative children. ART-mediated viral suppression led to the correction of CD4(+) immune activation to levels seen in uninfected children but did not increase the size of the memory CD4(+) T cell population. High levels of CD8(+) immune activation were also found in both naive and memory cell subsets. Antiretroviral treatment led to the normalization of CD8(+) T cell activation but did not correct the distribution of naive CD8(+) T cells. We also assessed PD-1 expression on CD8(+) T cells as a measure of immune dysfunction. Upregulation of PD-1 was highest in untreated children but persisted in ART-treated children compared to uninfected children. The mechanisms of immunopathogenesis in pediatric HIV infection likely involve distinct contributions from individual naive and memory T cells subsets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19182922      PMCID: PMC2858297          DOI: 10.1089/aid.2008.0138

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  36 in total

Review 1.  Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.

Authors:  Lieping Chen
Journal:  Nat Rev Immunol       Date:  2004-05       Impact factor: 53.106

Review 2.  New regulatory co-receptors: inducible co-stimulator and PD-1.

Authors:  Taku Okazaki; Yoshiko Iwai; Tasuku Honjo
Journal:  Curr Opin Immunol       Date:  2002-12       Impact factor: 7.486

Review 3.  Direct HIV cytopathicity cannot account for CD4 decline in AIDS in the presence of homeostasis: a worst-case dynamic analysis.

Authors:  R W Anderson; M S Ascher; H W Sheppard
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-03-01

Review 4.  The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation.

Authors:  James L Riley; Carl H June
Journal:  Blood       Date:  2004-09-07       Impact factor: 22.113

5.  Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial.

Authors:  Anita De Rossi; A Sarah Walker; Nigel Klein; Davide De Forni; Doug King; Diana M Gibb
Journal:  J Infect Dis       Date:  2002-07-05       Impact factor: 5.226

6.  Changes in thymic function with age and during the treatment of HIV infection.

Authors:  D C Douek; R D McFarland; P H Keiser; E A Gage; J M Massey; B F Haynes; M A Polis; A T Haase; M B Feinberg; J L Sullivan; B D Jamieson; J A Zack; L J Picker; R A Koup
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

7.  Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes.

Authors:  T H Finkel; G Tudor-Williams; N K Banda; M F Cotton; T Curiel; C Monks; T W Baba; R M Ruprecht; A Kupfer
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

8.  T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping.

Authors:  S Plaeger-Marshall; V Isacescu; S O'Rourke; J Bertolli; Y J Bryson; E R Stiehm
Journal:  Clin Immunol Immunopathol       Date:  1994-04

9.  Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.

Authors:  Salvador Resino; Isabel Galán; José M Bellón; M Luisa Navarro; Juan Antonio León; M Angeles Muñoz-Fernandez
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

10.  Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Authors:  Y Ishida; Y Agata; K Shibahara; T Honjo
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  9 in total

1.  HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions.

Authors:  Julia Foldi; Lina Kozhaya; Bret McCarty; Mussa Mwamzuka; Fatma Marshed; Tiina Ilmet; Max Kilberg; Adam Kravietz; Aabid Ahmed; William Borkowsky; Derya Unutmaz; Alka Khaitan
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

2.  Changes in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART.

Authors:  Kaitlin Rainwater-Lovett; Hope Nkamba; Mwangelwa Mubiana-Mbewe; Carolyn B Moore; Joseph Margolick; William J Moss
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-15       Impact factor: 3.731

3.  High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort.

Authors:  Damalie Nakanjako; Isaac Ssewanyana; Harriet Mayanja-Kizza; Agnes Kiragga; Robert Colebunders; Yukari C Manabe; Rose Nabatanzi; Moses R Kamya; Huyen Cao
Journal:  BMC Infect Dis       Date:  2011-02-08       Impact factor: 3.090

Review 4.  Biological Aging and Immune Senescence in Children with Perinatally Acquired HIV.

Authors:  Annalisa Dalzini; Maria Raffaella Petrara; Giovanni Ballin; Marisa Zanchetta; Carlo Giaquinto; Anita De Rossi
Journal:  J Immunol Res       Date:  2020-05-16       Impact factor: 4.818

Review 5.  The impact of differential antiviral immunity in children and adults.

Authors:  Andrew J Prendergast; Paul Klenerman; Philip J R Goulder
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

6.  Re-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infection.

Authors:  Jung Joo Hong; Praveen K Amancha; Kenneth Rogers; Aftab A Ansari; Francois Villinger
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

Review 7.  Immunity to HIV in Early Life.

Authors:  Maximilian Muenchhoff; Andrew J Prendergast; Philip Jeremy Renshaw Goulder
Journal:  Front Immunol       Date:  2014-08-12       Impact factor: 7.561

8.  Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset.

Authors:  Livio Azzoni; Russell Barbour; Emmanouil Papasavvas; Deborah K Glencross; Wendy S Stevens; Mark F Cotton; Avy Violari; Luis J Montaner
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

9.  CD4 Decay Rate as an Indicator of the Time Interval between Initial Infection and First Diagnosis among Drug-Naïve Human Immunodeficiency Virus Seropositive Individuals in Lagos, Nigeria.

Authors:  Babatunde Olanrewaju Motayo; Samson O Aturaka; Babatunde A Olusola; I Joseph Ogiogwa; Nataniel N Shidali; Olusola Akingbade; Adedayo O Faneye
Journal:  Med Princ Pract       Date:  2016-08-30       Impact factor: 1.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.